Skip to main content
Premium Trial:

Request an Annual Quote

NetGenics Snags Avalon as its Third DiscoveryCenter Customer


NetGenics has signed on Avalon Pharmaceuticals as the third customer for its recently launched DiscoveryCenter integration platform. Avalon joins Paradigm Genetics, which licensed the software in early October, and Schering AG, which is building a corporate-wide gene database using DiscoveryCenter components.

NetGenics recently completed the second stage of implementing the database at Schering, a project that began in June. Michael Bush, director of sales at NetGenics, said that over 100 Schering researchers in Germany and the US now have access to the same data sources through the system.

The implementation “has gone off without a hitch,” Bush said, adding that some researchers have already used the system to find similar projects within the organization and have begun to pool their resources, eliminating duplicated efforts.

Bush said that the Avalon and Paradigm installations are smaller than the Schering deployment. Around 10 people will use the system at Avalon, he said, with the option to add more users as necessary.

The Paradigm installation will begin this week.

The core software behind DiscoveryCenter is similar for every customer, Bush said, but different modules and data sources are added to meet the unique needs of an organization. In addition, the platform’s open API allows users to extend the system as needed.


Filed under

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.